ISIN

DGAP-News: Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225

Retrieved on: 
Wednesday, July 6, 2022 - 9:04am

Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177 and Ac-225.

Key Points: 
  • Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177 and Ac-225.
  • The agreement covers the development of a validated manufacturing process as well as the GMP-compliant production of clinical investigational products.
  • Ratio Therapeutics will use the newly built GMP suites at the Eckert & Ziegler production site near Boston, MA, USA, from July 2022 for this purpose.
  • As a radiopharmaceutical contract manufacturer, Eckert & Ziegler is able to produce small batches for Phase I, II and III clinical studies and large commercially applicable batch sizes.

DGAP-News: tokentus investment AG: Press release on the Virtual Annual General Meeting 2022

Retrieved on: 
Wednesday, July 6, 2022 - 7:05am

Frankfurt am Main, 6 July 2022 - At the Annual General Meeting of tokentus investment AG ("tokentus", ISIN: DE000A3CN9R8; WKN: A3CN9R; abbreviation: 14D), which was again held in virtual form yesterday, all of the resolutions proposed by the management were approved by the shareholders represented (presence: 45.59% of the share capital) by large majorities.

Key Points: 
  • Frankfurt am Main, 6 July 2022 - At the Annual General Meeting of tokentus investment AG ("tokentus", ISIN: DE000A3CN9R8; WKN: A3CN9R; abbreviation: 14D), which was again held in virtual form yesterday, all of the resolutions proposed by the management were approved by the shareholders represented (presence: 45.59% of the share capital) by large majorities.
  • During the annual general meeting, CEO Oliver Michel reported on the very successful 2021 financial year, which set the course for tokentus.
  • tokentus investment AG (ISIN: DE000A3CN9R8, WKN: A3CN9R; Ticker: 14D) is an investment company focusing on the blockchain market.
  • tokentus investment AG considers itself an investment pool and central access point for investors in the blockchain market.

DGAP-News: AUTO1 Group SE: AUTO1 and Ford digitize the car trade-in process

Retrieved on: 
Wednesday, July 6, 2022 - 7:05am

AUTO1 Group digitizes the trade-in process for Ford Germanys direct online sales as well as for Ford dealers and service partners.

Key Points: 
  • AUTO1 Group digitizes the trade-in process for Ford Germanys direct online sales as well as for Ford dealers and service partners.
  • AUTO1 Group provides online price estimates for private customers on the Ford website and supports Ford, authorized dealers, and service partners in lead generation and customer retention.
  • After a buyer has completed the configuration of the new car models "Ford Mustang Mach-E" or "Ford Explorer" on the Ford website, they enter the vehicle data of their used car at the end of the digital ordering process.
  • For optimized re-marketing of trade-in cars bought by Ford dealers, the AUTO1 EVA app has also been expanded exclusively for Ford dealers.

DGAP-News: Pacifico Renewables Yield AG fulfills 12 out of 13 sustainability targets in 2021 and sets new ambitious targets for 2022 and beyond

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

Gruenwald, July 6, 2022 Today, Pacifico Renewables Yield AG (ISIN: DE000A2YN371) (the Company, or together with its subsidiaries the Group), an independent producer of electricity from renewable sources, has published its sustainability report 2021 (the Report).

Key Points: 
  • Gruenwald, July 6, 2022 Today, Pacifico Renewables Yield AG (ISIN: DE000A2YN371) (the Company, or together with its subsidiaries the Group), an independent producer of electricity from renewable sources, has published its sustainability report 2021 (the Report).
  • Christoph Strasser, Co-CEO: We consider the publication of this second sustainability report another important achievement for our ambition to be at the forefront of corporate sustainability.
  • We are proud to have achieved all but one of our sustainability targets for 2021 which motivates us to become even more ambitious in the future.
  • The Group achieved all but one of the sustainability targets it set itself for 2021.

DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.

Key Points: 
  • We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.
  • We supply the most comprehensive integrated diagnostic solutions to support an appropriate use of antibiotics (antimicrobial stewardship), said Alexandre Mrieux, bioMrieux Chairman and CEO.
  • Our role within the joint venture is to develop and commercialize diagnostic tests, including Companion Diagnostics, which deliver rapid, reliable and actionable results.
  • bioMrieux has over 55 years of diagnostics expertise with more than 75% of its research and development budget focused on antimicrobial resistance.

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Retrieved on: 
Wednesday, July 6, 2022 - 6:50am

The aspiration is to succeed in the fight against AMR, which is a major public health threat.

Key Points: 
  • The aspiration is to succeed in the fight against AMR, which is a major public health threat.
  • The rise of antibiotic-resistant infections also called antimicrobial resistance, or AMR is indeed a looming global crisis, said Michel Pairet, Head of Boehringer Ingelheims Innovation Unit and Member of the Board of Managing Directors.
  • We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.
  • bioMrieux has over 55 years of diagnostics expertise with more than 75 percent of its research and development budget focused on antimicrobial resistance.

EQS-News: SunMirror AG: CORRECTION: TAKEOVER PROCEDURE OF LATITUDE 66 COBALT LIMITED WILL MORE LIKELY THAN NOT BE UNSUCCESSFULL - SUNMIRROR PUSHES FULL STEAM AHEAD WITH RESOURCE PROJECTMOOLYELLA LITHIUM

Retrieved on: 
Tuesday, July 5, 2022 - 6:05pm

CORRECTION: INVESTOR HAS NOT PAYED AS AGREED/ INDEPENDENT DIRECTORS OF LATITUDE 66 COBALT LIMITED CHANGE THEIR RECOMMENDATION FROM ACCEPT TO DECLINE AND HAVE WITHDRAWN THEIR ACCEPTANCE OF THE OFFER: TAKEOVER PROCEDURE OF LATITUDE 66 COBALT LIMITED WILL MORE LIKELY THAN NOT BE UNSUCCESSFULL - SUNMIRROR PUSHES FULL STEAM AHEAD WITH RESOURCE PROJECTMOOLYELLA LITHIUM

Key Points: 
  • CORRECTION: INVESTOR HAS NOT PAYED AS AGREED/ INDEPENDENT DIRECTORS OF LATITUDE 66 COBALT LIMITED CHANGE THEIR RECOMMENDATION FROM ACCEPT TO DECLINE AND HAVE WITHDRAWN THEIR ACCEPTANCE OF THE OFFER: TAKEOVER PROCEDURE OF LATITUDE 66 COBALT LIMITED WILL MORE LIKELY THAN NOT BE UNSUCCESSFULL - SUNMIRROR PUSHES FULL STEAM AHEAD WITH RESOURCE PROJECTMOOLYELLA LITHIUM
    Zug, Switzerland: 05.07.2022.
  • The deadline for SunMirror AGs ("SunMirror"; Xetra; Vienna: ROR1; ISIN CH0396131929) acquisition of Latitude 66 Cobalt Limited ("Lat66") will more likely than not unsuccessfully end on July 12, 2022.
  • Unfortunately, the investor who bindingly subscribed to the EUR 70 million authorized capital, only paid in a partial amount.
  • The independent directors of Lat66 have withdrawn their recommendation that Lat66 shareholders accept the takeover offer.

DGAP-News: EnviTec Biogas AG: Annual General Meeting rewards successful fiscal year

Retrieved on: 
Tuesday, July 5, 2022 - 4:06pm

Lohne/Saerbeck, 5 July 2022 At its third digital Annual General Meeting, EnviTec Biogas AG (ISIN: DE000A0MVLS8) looked back on the most successful fiscal year in the history of the company.

Key Points: 
  • Lohne/Saerbeck, 5 July 2022 At its third digital Annual General Meeting, EnviTec Biogas AG (ISIN: DE000A0MVLS8) looked back on the most successful fiscal year in the history of the company.
  • At this point, we can only emphasise once again the great commitment, conscientiousness and performance of all our employees, said Jrg Fischer, CFO of EnviTec Biogas AG.
  • EnviTec Biogas AG covers the entire value chain for the production of biogas, including the planning and turnkey construction of biogas plants and biogas upgrading plants as well as their commissioning.
  • EnviTec Biogas AG has been listed on the Frankfurt Stock Exchange since July 2007.

Deezer, a leading global music streaming platform, debuts today its listing on the Euronext Paris Stock Exchange

Retrieved on: 
Tuesday, July 5, 2022 - 3:09pm

PARIS, July 5, 2022 /PRNewswire/ -- Deezer (ISIN: FR001400AYG6) – (Mnemonic: DEEZR), the second largest independent music streaming platform in the world1, present in over 180 countries, is today listing on the Professional Segment (Compartiment Professionnel) of the regulated market of Euronext Paris.

Key Points: 
  • As one of the earliest French unicorns and member of France's Next40 index, Deezer is a pioneer of innovation in the music streaming industry.
  • It has developed a scalable and differentiated global platform, supported by its state-of-the-art product and successful hybrid B2B/B2C business model.
  • Jeronimo Folgueira, Chief Executive Officer of Deezer declared: "Deezer's IPO on Euronext Paris is a milestone in the company's history.
  • 1 Based on latest reported number of subscribers published by MIDiA (as of June 2021); excludes non-independent players being part of larger conglomerates (Apple Music, Amazon Music, YouTube Music, Tencent Music and NetEase Music).

Deezer, a leading global music streaming platform, debuts today its listing on the Euronext Paris Stock Exchange

Retrieved on: 
Tuesday, July 5, 2022 - 3:05pm

PARIS, July 5, 2022 /PRNewswire/ -- Deezer (ISIN: FR001400AYG6) – (Mnemonic: DEEZR), the second largest independent music streaming platform in the world1, present in over 180 countries, is today listing on the Professional Segment (Compartiment Professionnel) of the regulated market of Euronext Paris.

Key Points: 
  • As one of the earliest French unicorns and member of France's Next40 index, Deezer is a pioneer of innovation in the music streaming industry.
  • It has developed a scalable and differentiated global platform, supported by its state-of-the-art product and successful hybrid B2B/B2C business model.
  • Jeronimo Folgueira, Chief Executive Officer of Deezer declared: "Deezer's IPO on Euronext Paris is a milestone in the company's history.
  • 1 Based on latest reported number of subscribers published by MIDiA (as of June 2021); excludes non-independent players being part of larger conglomerates (Apple Music, Amazon Music, YouTube Music, Tencent Music and NetEase Music).